Related Experiment Video
Updated: May 5, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Effect of down-regulated transcriptional repressor ZEB1 on the epithelial-mesenchymal transition of ovarian cancer
Dengyu Chen1, Jing Wang, Yunxia Zhang
1*Department of Pathogenic Biology and Immunology of Medical College, Southeast University, Nanjing, China; †Department of Microbiology, Bengbu Medical School, Bengbu, PR China; and ‡Department of Gynecology and Obstetrics, Zhongda Hospital, Medical School, Southeast University, Nanjing, PR China.
Background:
Progress has been made against early events of malignant transformation and drug resistance associated with epithelial ovarian cancer; uncontrolled metastases, however, still accounts for most patient deaths. The molecular mechanism that regulates the process of epithelial ovarian cancer metastases is not yet clearly understood. The purpose of this study was to investigate the effect of down-regulating the transcriptional repressor zinc-finger E-box-binding homeobox 1 (ZEB1) on an epithelial-mesenchymal transition (EMT) of human ovarian cancer SKOV3 cell line in vitro and in vivo.
Methods:
The human ovarian cancer cells SKOV3 and HO8910 were transfected with an expression vector-based small hairpin RNA (shRNA) targeting ZEB1 (shZEB1), and the stably transfected cells were selected. Colony-forming, wound-healing, and cellular migration assays were respectively used. The tumorigenicity of shZEB1-SKOV3 was also evaluated in mice.
Results:
The shZEB1-SKOV3 and shZEB1-HO8910 cells showed a lower level of ZEB1 expression and weaker cell migration than the control cells. Moreover, down-regulating ZEB1 expression with shRNA in the cells enhanced the expression of miR-200c that acted as a tumor suppressor to inhibit the epithelial-mesenchymal transition of shZEB1-SKOV3 cells and to block shZEB1-SKOV3 cell metastasis in vivo. The shRNA-mediated down-regulation ZEB1 in SKOV3 cells significantly decreased the tumor growth in the xenograft mice.
Conclusion:
The shZEB1-mediated down-regulation of the ZEB1 expression in the SKOV3 cells may be considered for future clinical trials.
Insights
Down-regulating zinc-finger E-box-binding homeobox 1 (ZEB1) in ovarian cancer cells inhibits metastasis and tumor growth. This approach, targeting ZEB1, shows promise for future clinical applications in treating epithelial ovarian cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Metastasis Research
Background:
- Epithelial ovarian cancer (EOC) metastasis remains a primary cause of patient mortality.
- The molecular mechanisms driving EOC metastasis are not fully understood.
- Targeting key regulators of epithelial-mesenchymal transition (EMT) is crucial for EOC treatment.
Purpose of the Study:
- To investigate the impact of down-regulating zinc-finger E-box-binding homeobox 1 (ZEB1) on EMT in human ovarian cancer cells.
- To evaluate the in vitro and in vivo effects of ZEB1 suppression on ovarian cancer cell behavior.
Main Methods:
- Human ovarian cancer cell lines (SKOV3, HO8910) were transfected with small hairpin RNA (shRNA) targeting ZEB1.
- Stable cell lines (shZEB1) were selected and assessed using colony-forming, wound-healing, and migration assays.
- Tumorigenicity of ZEB1-downregulated cells was evaluated in a mouse xenograft model.
Main Results:
- Down-regulation of ZEB1 expression reduced cell migration and epithelial-mesenchymal transition (EMT) in ovarian cancer cells.
- ZEB1 suppression enhanced miR-200c expression, a known tumor suppressor.
- Reduced ZEB1 levels significantly decreased tumor growth in vivo and inhibited metastasis.
Conclusions:
- Down-regulating ZEB1 expression effectively inhibits ovarian cancer cell metastasis and growth.
- The ZEB1/miR-200c axis plays a critical role in regulating EMT and metastasis in ovarian cancer.
- Targeting ZEB1 represents a potential therapeutic strategy for epithelial ovarian cancer, warranting further clinical investigation.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Abnormal Proliferation
MicroRNAs
MicroRNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

